The most active researchers, institutions, and subtopics in Systemic Lupus Erythematosus, from recent PubMed records. Public authorship only, every figure verifiable by PMID.
Analyzed 104 recent PubMed papers (2021-2026) matching "systemic lupus erythematosus anifrolumab belimumab". Source: NLM PubMed. Generated July 2026.
| # | Researcher | Affiliation | Papers |
|---|---|---|---|
| 1 | Lee Young Ho | Korea University Anam Hospital | 4 |
| 2 | Doria Andrea | University of Padua | 4 |
| 3 | Tani Chiara | University of Pisa | 4 |
| 4 | Chasset François | Sorbonne Université | 4 |
| 5 | Arnaud Laurent | Hôpitaux Universitaires de Strasbourg | 4 |
| 6 | Mosca Marta | University of Pisa | 3 |
| 7 | Bertsias George | Rheumatology and Clinical Immunology | 3 |
| 8 | Song Gwan Gyu | Korea University Anam Hospital | 3 |
| 9 | Bortoluzzi Alessandra | University of Ferrara and Azienda Ospedaliero-Universitari | 3 |
| 10 | Iaccarino Luca | University of Padua. | 3 |
| 11 | Gatto Mariele | University of Turin | 3 |
| 12 | Fanouriakis Antonis | Rheumatology and Clinical Immunology Unit | 3 |
| 13 | Anders Hans-Joachim | Hospital of the Ludwig Maximilians University Munich | 3 |
| 14 | Moroni Gabriella | Humanitas University | 2 |
| 15 | Roccatello Dario | University Center of Excellence on Nephrology | 2 |
| 16 | Blagov Alexander | 125315 Moscow | 2 |
| 17 | Orekhov Alexander | 125315 Moscow | 2 |
| 18 | Lopes Almeida Gomes Lais | Corporal Michael J. Crescenz Veterans Affairs Medical Cent | 2 |
Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.
Recent advances in the management of pediatric neuropsychiatric lupus from conventional therapies to novel immunomodulators. (2026) · PMID 42370576
Evaluating the comparative efficacy of belimumab vs. anifrolumab in systemic lupus erythematosus: a response. (2026) · PMID 42334565
Efficacy and safety of belimumab and anifrolumab in systemic lupus erythematosus: A systematic review and network meta-analysis. (2026) · PMID 42308962
Advances and unmet needs in the management of proliferative lupus nephritis: evidence, guidelines, and emerging therapies. (2026) · PMID 42226627
Comparative study of adverse drug reactions associated with anifrolumab and belimumab for the treatment of systemic lupus erythema (2026) · PMID 42224076
A full Systemic Lupus Erythematosus brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.